Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Motivating Activity Through Text Communications - Helping Adults Increase Movement (MATCH AIM)

30 de julio de 2026 actualizado por: David Conroy, University of Michigan

Motivating Activity Through Text - Comparing Human and AI Messages (MATCH AIM) Trial

The goal of this clinical trial is to compare the effect of different types of text messages on physical activity levels of middle-aged and older adults and to determine whether these messages are effective in adults age 40 and older who are engaging in less than 90 minutes per week of moderate or higher intensity physical activity. The main questions it aims to answer are:

  • Which types of motivational messages show the greatest effects on changes in daily step counts in a 3-month precision text messaging intervention?
  • What are the effects of personalized text messages on automatic affective evaluations, habit strength (experienced automaticity), exercise identity, working memory capacity, and processing speed?

Participants will:

  • Wear a Fitbit activity tracker continuously for 3 months and are encouraged to continue wearing it through 6 months.
  • Wear an activPAL activity monitor on their thigh for 7-day assessment periods at the beginning of the study, at 3 months, and at 6 months.
  • Complete 3 cognitive assessments ("brain games") per day on their smartphone during the 7-day assessment periods at baseline, 3 months, and 6 months.
  • Be asked to set goals to increase their daily steps over the first 3 months of the study.
  • Receive up to 4 motivational text messages per day for 3 months to encourage physical activity.
  • Keep study-related apps (Fitbit app, AIM app, MetricWire app) open in the background on their smartphone.
  • Complete questionnaires at the beginning of the study, at 3 months, and at 6 months

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

150

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Ann M Mehringer
  • Número de teléfono: 734-647-6050
  • Correo electrónico: amehring@umich.edu

Ubicaciones de estudio

  • Estados Unidos
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48109
        • Reclutamiento
        • University of Michigan
        • Investigador principal:
          • David E Conroy, PhD
        • Contacto:
          • David E Conroy, PhD
          • Número de teléfono: 734-647-8404
          • Correo electrónico: deconroy@umich.edu
        • Contacto:
          • Ann M Mehringer
          • Número de teléfono: 734-647-6050
          • Correo electrónico: amehring@umich.edu

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Be 40 years of age or older
  • Own a smartphone running an Android or iOS operating system
  • Have proficiency with the English language
  • Be capable of providing informed consent
  • Be able to perform moderate physical activity without restrictions
  • Be willing to complete the entire 6-month protocol
  • Be willing to establish a 12-hour window - beginning no later than 9:45 am and ending no later than 9:45 pm - for receiving text messages.

Exclusion Criteria:

  • Residing outside of the continental United States
  • Self-reporting 90 minutes or more of moderate-to-vigorous intensity physical activity per week
  • contraindications to normal physical activity as identified on the Physical Activity Readiness Questionnaire (PAR-Q)
  • Mobility restrictions that interfere with unassisted physical activity
  • Being pregnant or planning to become pregnant during the study
  • Planning to undergo surgery during the course of the study protocol
  • Having a prior diagnosis of Alzheimer's disease or a related dementia
  • Evidence of mild cognitive impairment as indicated by a mini-Montreal Cognitive Assessment (MoCA) test score of 12 or higher
  • Concurrent participation in another study involving weight loss or physical activity
  • Failure to respond to at least 85% of Ecological Momentary Assessment (EMA) prompts during the 7-day qualification phase.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Cuadruplicar

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Validated library of text messages
Participants in this arm will receive motivational text messages that have been written and used in previous studies.
Conductual: Text Messaging Intervention

Participants will receive up to 4 motivational text messages per day during a self-selected 12-hour window. These messages focus on two content areas: 1) Move more, and 2) sit less. Delivery of these messages occurs in two phases:

  1. Random AIM (month 1): Messages are sent at random times within the participant's window to collect baseline data on their behavioral responses.
  2. Precision AIM (months 2 and 3): Messages are sent at optimized times based on person-specific models that are created from the individual's previous responses to text messages from month 1.
Experimental: Newly created text messages
Participants in this arm will receive motivational text messages that have not been used in previous studies.
Conductual: Text Messaging Intervention

Participants will receive up to 4 motivational text messages per day during a self-selected 12-hour window. These messages focus on two content areas: 1) Move more, and 2) sit less. Delivery of these messages occurs in two phases:

  1. Random AIM (month 1): Messages are sent at random times within the participant's window to collect baseline data on their behavioral responses.
  2. Precision AIM (months 2 and 3): Messages are sent at optimized times based on person-specific models that are created from the individual's previous responses to text messages from month 1.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Daily Step Count
Periodo de tiempo: The activPAL is worn on the thigh for a 7-day assessment period before the intervention begins (baseline), after 3 months of intervention, and then again 3 months after the intervention is complete. The total time frame is 6 months.
The primary outcome measure is the average daily step count, which is assessed using a blinded, research-grade activPAL activity monitor, worn on the thigh for a 7-day assessment period.
The activPAL is worn on the thigh for a 7-day assessment period before the intervention begins (baseline), after 3 months of intervention, and then again 3 months after the intervention is complete. The total time frame is 6 months.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Mechanisms of Behavior Change for Adherence: Habit Strength
Periodo de tiempo: These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Habit Strength will be assessed using the Behavioral Automaticity Index from the Self-Report Habit Index to measure how automatic the exercise behavior has become. Scores are calculated as the average item responses and range from 1 to 7 with higher scores reflecting greater experienced automaticity (i.e., stronger habits).
These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Mechanisms of Behavior Change for Adherence: Exercise Identity (Reflective)
Periodo de tiempo: These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Exercise Identity will be assessed using the Exercise Identity Scale to see how much participants view themselves as "exercisers". Scores are based on the average item response and range from 1 to 7 with higher scores representing a stronger exercise identity.
These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Mechanisms of Behavior Change for Adherence: Automatic Affective Evaluations
Periodo de tiempo: These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Automatic Affective Evaluations will be assessed using a Single-Category Implicit Association Test (SCIAT) to assess non-conscious attitudes toward physical activity. Scores are standardized mean differences of response times between blocks of trials where physical activity is paired with unpleasant attributes and blocks of trials where physical activity is paired with pleasant attributes. Higher scores indicate more favorable automatic affective evaluations of physical activity.
These secondary outcomes are collected at the same major time points as the primary outcome: baseline (month 0), post-intervention (month 3), and follow-up (month 6).
Ambulatory Cognitive Function: Processing Speed
Periodo de tiempo: These secondary outcomes are collected at the same major time points as the primary outcome: Baseline (month 0), post-intervention (month 3), and follow-up (6 month).
Processing Speed will be assessed with the Mobile Monitoring of Cognitive Change (M2C2) Symbol Search Task. Scores are based on response times for accurate trials so there is no fixed range for scores. Shorter response times indicate faster (better) processing speed; longer response times indicate slower (worse) processing speed.
These secondary outcomes are collected at the same major time points as the primary outcome: Baseline (month 0), post-intervention (month 3), and follow-up (6 month).
Ambulatory Cognitive Function: Working Memory Capacity
Periodo de tiempo: These secondary outcomes are collected at the same major time points as the primary outcome: Baseline (month 0), post-intervention (month 3), and follow-up (6 month).
Working Memory Capacity will be measured using the M2C2 Grid Memory Task. Scores are based on response accuracy measured as a Euclidean distance score. Shorter distance scores indicate more working memory capacity; longer distance scores indicate less working memory capacity.
These secondary outcomes are collected at the same major time points as the primary outcome: Baseline (month 0), post-intervention (month 3), and follow-up (6 month).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

University of Michigan

Colaboradores

National Institute on Aging (NIA)

Investigadores

  • Investigador principal: David E Conroy, PhD, University of Michigan

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

11 de mayo de 2026

Finalización primaria (Estimado)

3 de mayo de 2027

Finalización del estudio (Estimado)

2 de agosto de 2027

Fechas de registro del estudio

Enviado por primera vez

4 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de mayo de 2026

Publicado por primera vez (Actual)

18 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

31 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • HUM00262651
  • P30AG086637 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data (IPD) underlying the results reported in primary and secondary publications will be shared. This includes baseline behavioral metrics, coarsened demographics, post-intervention outcomes, and follow-up data. To protect participant privacy, all data will be stripped of direct identifiers, ages will be binned into 5-to-10-year bands, geographic markers restricted to broad regions, and timeline dates converted to "days since randomization." Raw, free-text qualitative journal entries will be suppressed entirely due to re-identification risks.

Marco de tiempo para compartir IPD

Data and supporting documentation will be made available concurrently with the primary peer-reviewed publication of the trial results and will remain accessible for 5 years post-publication. This immediate availability complies with the NIH Data Management and Sharing Policy.

Criterios de acceso compartido de IPD

Access is restricted to qualified external researchers affiliated with an accredited academic or non-profit research institution. Applicants must submit a formal, written research proposal detailing a sound scientific hypothesis and an analytical plan, alongside documentation of local IRB approval/waiver. Approved requestors and their sponsoring institutions must sign a legally binding Data Use Agreement (DUA) that strictly prohibits any re-identification or external data-linking attempts.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir